Who owns Solid Biosciences Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of SLDB from SEC Form 13F filings across 158 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 158 institutions disclosed 118.9M shares of Solid Biosciences Inc. worth $856.7M — about 78.7% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
158
13F holders
$856.7M
value, 2026 filers
78.7%
of shares outstanding (118.9M sh)
26
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of SLDB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 12.0M | $87.0M | 0.9% | 8% | 0.0% |
| 2 | PERCEPTIVE ADVISORS LLC | 11.9M | $86.1M | 1.5% | 7.9% | 0.0% |
| 3 | Bain Capital Life Sciences Investors, LLC | 9.8M | $70.9M | 4.8% | 6.5% | 0.0% |
| 4 | Siren, L.L.C. | 7.7M | $55.6M | 1.3% | 5.1% | 0.0% |
| 5 | FMR LLC | 7.3M | $52.6M | 0.0% | 4.8% | +5.8% |
| 6 | BlackRock, Inc. | 6.8M | $49.4M | 0.0% | 4.5% | -1.4% |
| 7 | RTW INVESTMENTS, LP | 5.9M | $42.7M | 0.4% | 3.9% | +51.7% |
| 8 | ARMISTICE CAPITAL, LLC | 4.5M | $32.5M | 0.4% | 3% | +5.1% |
| 9 | FRANKLIN TEMPLETON INC | 4.2M | $27.3M | 0.0% | 2.8% | +21.9% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0M | $28.7M | 0.0% | 2.6% | -1.0% |
| 11 | Deep Track Capital, LP | 3.6M | $25.8M | 0.4% | 2.4% | 0.0% |
| 12 | STATE STREET CORP | 3.3M | $24.0M | 0.0% | 2.2% | -20.4% |
| 13 | AMERIPRISE FINANCIAL INC | 2.9M | $21.1M | 0.0% | 1.9% | +31.1% |
| 14 | Janus Henderson Group Ltd.NEW | 2.8M | $20.5M | 0.0% | 1.9% | new |
| 15 | Alyeska Investment Group, L.P. | 2.4M | $17.2M | 0.0% | 1.6% | +4.5% |
| 16 | CITADEL ADVISORS LLC | 2.1M | $15.2M | 0.0% | 1.4% | -25.5% |
| 17 | Vestal Point Capital, LP | 2.1M | $15.1M | 0.4% | 1.4% | -3.5% |
| 18 | Redmile Group, LLC | 1.9M | $14.1M | 1.0% | 1.3% | -0.2% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $13.8M | 0.0% | 1.3% | -1.5% |
| 20 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.5M | $10.9M | 0.0% | 1% | 0.0% |
| 21 | DIMENSIONAL FUND ADVISORS LP | 1.4M | $10.2M | 0.0% | 0.9% | +11.7% |
| 22 | JPMORGAN CHASE & CO | 1.2M | $8.5M | 0.0% | 0.8% | +319.4% |
| 23 | GOLDMAN SACHS GROUP INC | 1.2M | $8.4M | 0.0% | 0.8% | -27.8% |
| 24 | MORGAN STANLEY | 1.2M | $8.3M | 0.0% | 0.8% | +352.0% |
| 25 | Qube Research & Technologies Ltd | 1.0M | $7.4M | 0.0% | 0.7% | +643.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.